Biological resources are the foundation of all biological sciences research. They provide the source material for scientific investigation, leading to many of the discoveries on which biotechnology is founded.
This document reflects recent efforts made by the OECD to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.
English, , 327kb
The OECD should strengthen its contribution to work on biotechnology as a driver for sustainable growth, focusing on the issues identified and conclusions reached in this paper.
English, , 365kb
This guidance provides the basis for best practice in the management of biological resource centres and all laboratories maintaining replicable biological materials.
English, , 260kb
This document provides a framework for the national certification (independent review by third party) of biological resource centres as defined by the OECD. Compliance with this guidance is mandatory for those bodies that are part of a Global Biological Resource Centre Network.
As biotechnology becomes increasingly viewed as a strategic sector, the need for reliable statistics from which informed policy decisions can be made grows. This report provides an update on the biotechnology industry, based on primarily official statistical sources.
This paper provides input and a framework for a broader discussion of the identification of user needs that should inform the development of biotechnology statistics and indicators.
This booklet describes how biotechnology and genomics science can be used to fight neglected infectious diseases as well as reviewing the challenges facing Governments to overcome market failure in supply of products. It draws on discussions a...
English, , 123kb
Rapporteurs' report of the Conference on Biotechnology for Infectious Diseases: Addressing the Global Needs, held in Lisbon, Portugal on - 7-9 October 2002.
English, , 669kb
This report presents the findings of an OECD Workshop held in Berlin to establish the impact of patents and licensing on development and access to genetic technology. Few topics in the life sciences today provoke as much debate as the availability of patent protection on "genetic inventions".